Jana Makuc

Dr. Jana Makuc

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2021 in Bosnian Journal of Basic Medical Sciences
Verified
Journal Article
Open access
PDF file
JLJernej Letonja
Jernej Letonja
MZMatej Završnik
Matej Završnik
JMJana Makuc
Jana Makuc
MŠMaja Šeruga
Maja Šeruga
APAna Peterlin
Ana Peterlin
Daniel PetrovicDaniel Petrovic
Daniel Petrovic
The global prevalence for diabetes mellitus nearly doubled from 4.7% in 1980 to 8.5% in 2014. Sirtuin 1 (SIRT1) is an NAD+-dependent deacetylase that is expressed in a variety of tissues. It modifies proteins that participate in DNA repair, stress, and inflammatory response. The aim of the study was to investigate the relationship between SIRT1 rs7069102 polymorphism and diabetic nephropathy (DN) in patients with T2DM. In our retrospective association study, we included 724 Slovene (Caucasian) patients who have had T2DM for at least 10 years. We classified the participants into two groups, the first group was comprised of 301 patients with DN, and the second (control) group was comprised of 423 patients without DN. We analyzed the rs7069102 polymorphism using StepOne Real-Time PCR System and TaqMan SNP Genotyping Assay. We found a statistically significant difference in the distribution of rs7069102 genotypes and alleles between the two groups. We used logistic regression analysis and adjusted for systolic pressure, arterial hypertension (AH), duration of AH, triglycerides, the value of HbA1c, carotid disease, diabetic foot, and DR. Furthermore, we discovered that patients with the CC genotype are significantly more likely to develop DN according to both the codominant (OR = 1.94; 95% CI = 1.09 – 3.45; p = 0.02) and recessive (OR = 2.39; 95% CI = 1.12 – 5.08; p = 0.02) models of inheritance. We found a significant association between the SIRT1 rs7069102 polymorphism and DN in T2DM. We speculate that SIRT1 rs7069102 might be an interesting marker of DN.

1 May 2020 in Gene
Verified
Journal Article
Closed access
ICInes Cilenšek
Ines Cilenšek
MŠMaja Šeruga
Maja Šeruga
JMJana Makuc
Jana Makuc
MZMatej Završnik
Matej Završnik
DPDanijel Petrovič
Danijel Petrovič

23 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JMJana Makuc
Jana Makuc
ALAna Ogrič Lapajne
Ana Ogrič Lapajne
ŠHŠpela Hvalec
Špela Hvalec
MJMojca Jensterle
Mojca Jensterle
Andrej JanežAndrej Janež
Andrej Janež
Background/Objectives: To assess the factors affecting the unconscious bias of healthcare professionals (HCPs) in obesity care. Methods: A cross-sectional, non-interventional, descriptive study collecting data via an online survey system was distributed via e-mail to 11,597 members of the Medical Chamber of Slovenia. Physicians were assigned into six HCP categories: (junior) resident physicians, primary care physicians (PCPs), internal medicine specialists, surgeons, dentists, and others. The online questionnaire was active for two weeks. Results: A total of 1248 physicians opened the survey link (10.8% response rate). Of the 898 physicians that engaged in the survey, 789 fully completed the questionnaire. Out of those physicians, 93.6% agreed that obesity is a disease, 83.7% were familiar with the definition, and 75.5% of HCPs were professionally interested in the subject. Overall, 39% of HCPs use the ICD obesity code, primarily primary care physicians and specialists in internal medicine. Notably, 82.0% of HCPs identified lifestyle change as the most effective intervention and believed that patients could lose weight with a serious attempt at a lifestyle change. This belief was particularly supported by male HCPs and HCPs under 40 years of age, who felt that patients were entirely responsible for their weight. The unconscious bias decreased with an increase in the HCPs’ body mass index (BMI), but at the same time, physicians with a higher BMI found obesity to be less important than other diseases (p = 0.036). Using composite answers, we found that the unconscious bias of HCPs toward obesity and effective obesity care was significantly related to gender (p = 0.017), age (p < 0.001), and BMI (p = 0.005), and was independent of an area of expertise. Conclusions: HCPs’ area of expertise impacted their professional standpoint (suggesting conscious bias), whereas male gender, a younger age, and a lower BMI affected unconscious bias toward obesity and its effective care. Despite their limitations, including the self-reported nature of the data, our findings can help to individualize educational strategies and create a more equitable environment in obesity healthcare.

24 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JMJana Makuc
Jana Makuc
Miodrag JanićMiodrag Janić
Miodrag Janić
Glucagon-like peptide-1 (GLP-1) receptor agonists and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide have transformed the treatment of type 2 diabetes mellitus (T2DM) and obesity. Although these agents share an incretin-based mode of action, they differ in structure, receptor pharmacology, pharmacokinetics, formulation, and titration schedule, and the individual treatment response is highly heterogeneous. Switching between agents occurs in roughly one in four to one in three patients in real-world practice, yet no standardized protocol exists: recommendations rest largely on expert consensus, and no official dose-equivalence chart has been issued. This narrative review critically evaluates evidence for switching and cross-titration between incretin-based therapies; summarizes, insofar as they inform switching decisions, the pharmacological diversity and response heterogeneity that motivate switching; and translates the evaluated evidence into a stepwise practical switching algorithm, developed by the authors as an evidence-informed expert synthesis that has not been formally validated. Special populations, persistence, discontinuation, weight regain, and the emerging pipeline of multi-agonists and oral small molecules are addressed where they modify switching decisions. Until the evidence matures, individualized reason-specific transitions that preserve the continuity of incretin-based therapy offer the most defensible framework for practice.

4 August 2026 in BMC Nursing
Verified
Journal Article
Open access
PDF file
JMJana Makuc
Jana Makuc
ALAna Ogrič Lapajne
Ana Ogrič Lapajne
ŠHŠpela Hvalec
Špela Hvalec
MJMojca Jensterle
Mojca Jensterle
Andrej JanežAndrej Janež
Andrej Janež
Background: The understanding of obesity is evolving from a perceived lifestyle-related condition to a chronic, biologically driven disease. Perception of obesity as a disease among health care professionals is important for effective evidence-based obesity care. Nurses have the most sustained patient contact and play an important role in obesity prevention and management, yet their role in this context remains underexplored. We therefore assessed the perceptions and attitudes towards obesity and obesity care in a Slovenian nursing care cohort. Methods: Non-interventional, descriptive, cross-sectional study collecting data via an online survey system was distributed to nationwide membership of the Nurses and Midwives Association of Slovenia via their digital communication channels. The online questionnaire was active for three months. Data was integrated with previously obtained responses from physicians, to enable cross-professional comparison. Results: The majority of respondents agreed that obesity is a disease (82.7%), that is equally important as other chronic diseases (86.9%). Most feel uncomfortable talking about obesity (54.8%) and assume patients fully responsible for their weight (58.1%), which correlates to a lower level in nursing care education. Those with higher nursing care education reported more positive professional attitudes toward obesity ( p < 0.001). A strong misalignment between professional/personal standpoint was confirmed ( p < 0.001), however, personal attitude was a strong positive predictor of professional attitude ( p < 0.001). Female respondents showed more positive attitudes than males ( p = 0.002). Participants within family medicine model practice (registered nurses with special knowledge in chronic diseases) have the least problems addressing obesity (25%). Conclusions: The concept of obesity being a disease is not fully adopted in nursing care respondents and a strong misalignment between the professional/personal standpoint exists. Personal attitude and education level were positive predictors of professional attitude towards obesity. Female respondents showed more positive attitudes. These findings highlight the importance of educational interventions aimed not only at increasing professional knowledge but also at addressing personal obesity-related attitudes among nursing professionals.